A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of IBI112 induction therapy in patients with moderate and severe
active Ulcerative Colitis (UC) to achieve clinical remission.